Kangah Orphée, Zongo Issaka, Haro Alassane, Yavo William
National Institute of Public Health, Abidjan BP V 47, Côte d'Ivoire.
Institut de Recherche en Sciences de la Santé-Direction Régionale de l'Ouest (IRSS-DRO), Bobo-Dioulasso BP 2779, Burkina Faso.
Trop Med Infect Dis. 2024 Dec 30;10(1):10. doi: 10.3390/tropicalmed10010010.
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3-59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d'Ivoire, malaria remains a high priority and accounts for the majority of consultations and deaths in children under five. The recent revision of the criteria for the introduction of seasonal malaria chemoprevention has made the north of Côte d'Ivoire, where malaria transmission is seasonal, eligible for the SMC. We conducted a pilot study in this part of the country to assess the acceptability and feasibility of five cycles of SMC in 1701 children. Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine + amodiaquine (SP + AQ) was administered monthly to eligible children over five months. A qualitative approach and quantitative surveys were used to assess the strategy acceptability and feasibility in the study area. Overall, there was a positive perception, attitude, and adherence towards the seasonal malaria chemoprevention in this study area.
季节性疟疾化学预防（SMC）是世界卫生组织针对疟疾传播具有季节性的萨赫勒和次萨赫勒地区3至59个月大儿童推荐的一项策略。在科特迪瓦，疟疾仍然是重中之重，五岁以下儿童的多数咨询和死亡病例都由疟疾导致。最近对引入季节性疟疾化学预防标准的修订，使疟疾传播具有季节性的科特迪瓦北部符合开展季节性疟疾化学预防的条件。我们在该国这一地区开展了一项试点研究，以评估1701名儿童进行五个周期季节性疟疾化学预防的可接受性和可行性。对符合条件的五个月以上儿童每月给予磺胺多辛-乙胺嘧啶+阿莫地喹（SP+AQ）进行季节性疟疾化学预防。采用定性方法和定量调查来评估该策略在研究区域的可接受性和可行性。总体而言，该研究区域对季节性疟疾化学预防有着积极的认知、态度和依从性。
